Please log in to see the full text of this API!

Relugolix

  • Synonyms: TAK-385; RVT-601
  • ATC: H01CC54
  • Use: Lorem 
  • Chemical name: Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam
  • Formula: Lorem ipsum dolor sit amet,
  • MW:623.6 g/mol
  • CAS-RN:737789-87-6
  • InChI Key:AOMXMOCNKJTRQP-UHFFFAOYSA-N
  • InChI:InChI=1S/C29H27F2N7O5S/c1-​36(2)​14-​19-​24-​26(39)​38(22-​12-​13-​23(42-​3)​34-​33-​22)​29(41)​37(15-​18-​20(30)​6-​5-​7-​21(18)​31)​27(24)​44-​25(19)​16-​8-​10-​17(11-​9-​16)​32-​28(40)​35-​43-​4/h5-​13H,​14-​15H2,​1-​4H3,​(H2,​32,​35,​40)

Substance Classes

Synthesis Path
















Substances Referenced in Synthesis Path

CAS-RN Formula Chemical Name CAS Index Name
5332-96-7 C9H9NO3 4-nitrophenylacetone
105-56-6 C5H7NO2 ethylcyanoacetate
174072-89-0 C14H14N2O4S Ethyl 2-amino-4-methyl-5-(4-nitrophenyl)thiophene-3-carboxylate
308831-93-8 C17H18N2O6S Ethyl 2-[(ethoxycarbonyl)amino]-4-methyl-5-(4-nitrophenyl)thiophene-3-carboxylate
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem

Trade Names

Country Trade Name Vendor Annotation
J Lorem Lorem
USA Lorem Lorem
EU Lorem Lorem in comb. with estradiol and norethisterone acetate
(wfm = withdrawn from market)

Formulations

  • Loremipsumdolorsitamet,

References

    • Tukun, F. L. et al., Molecules, (2017) 22, 2188.
    • Osuga, Y. et al., Fertility and Sterility, (2021), 115(2), 397-405.
    • a) Miwa, K. et al., J. Med. Chem., (2011) 54, 4998-5012.
    • Sasaki, S. et al., J. Med. Chem., (2003) 46, 113-124.
    • US 9 999 999 (Takeda; 27.11.2007; appl. 29.7.2005; JP-prior. 28.1.2004).
    • US 9 999 999 (Takeda; 15.11.2011; appl. 31.8.2007; JP-prior. 29.1.2003, 28.1.2004).
    • b) WO 9999 999999 (Takeda; 3.4.2014; appl. 27.9.2013; JP-prior. 28.9.2012).
  • Alternative method:

    • WO 9999 999999 (Suzhou Peng Xu Pharmatech; 11.2.2021; appl. 3.8.2020; CN-prior. 5.8.2019).
  • Treatment of prostate cancer:

    • US 99 999 999 (Myovant Sci./Takeda; 29.9.2020; appl. 6.9.2019; EP-prior. 29.9.2017/US-prior. 30.9.2016).
Cookie-Einstellungen